Ubs Asset Management Americas Inc Dr Reddys Laboratories LTD Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 16,558 shares of RDY stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,558
Previous 30,412
45.55%
Holding current value
$1.32 Million
Previous $2.23 Million
43.45%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
233Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$164 Million0.34% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$163 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$161 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$159 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$143 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $13.2B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...